Eyeworld

12 | EYEWORLD | WINTER 2026 ASCRS NEWS continued from page 10 side. The IOL was significantly tilted. There was 5 D of astigmatism, and the patient was 20/80. According to the paper's authors, surgery was performed extraocular and "involved creating a partial-thickness scleral tunnel to embed the exposed haptic, securing it with a 10-0 nylon suture, and covering the site with a scleral patch graft." As a result of the procedure, the patient's vision improved to 20/20. The IOL remained in a stable, untilted position at 4 months. Artificial corneal implant in iridocorneal endothelial syndrome with secondary glaucoma: case report The first case, to the authors' knowledge, of femtosecond laser- assisted KeraKlear (KeraMed) artificial corneal implantation in a patient with iridocorneal endo- thelial syndrome with secondary glaucoma in her right eye was described in this paper. The patient had been on glaucoma drops long term and had a 3-year history of blurred vision, which progressively worsened as a sub- epithelial fibrotic membrane enlarged, reducing her visual acuity from 0.8 to 0.1 (Snellen). The patient underwent the femtosecond laser-assist- ed procedure with KeraKlear implantation, and at 3 months had a stable prosthetic, CDVA of 0.3 Snellen, and stable endothelial cell counts that were comparable to the unoperated left eye. The authors concluded that the "KeraKlear was a useful alternative to keratoplasty in this setting, and unlike keratoplasty has not been shown to worsen glaucoma." Trench-assisted stop-and-cut technique: superficial nucleus trench assists the occlusion-free chopping technique in cataract surgery A modified stop-and-chop tech- nique that achieved complete chopping without occlusion was described in this paper, which the authors wrote is helpful for soft nuclei. "The only prerequisite is stabilization of the nucleus," they wrote. The authors described cracking the nucleus in two, rotating it 90 degrees, and creating a superficial groove/trench in the lower nuclear half. From there, "the chopper is inserted into the equator area through the trench underneath the capsu- lorhexis edge and moved horizontally from the periphery toward the [ultrasound] tip to split the nucleus without occlusion." Clinical evaluation of topical losartan in patients with corneal haze after PRK: case series This case series of 6 patients (6 eyes) sought to evaluate the ef- fect of losartan, 0.8%, on corneal haze from subepithelial stromal fibrosis after PRK. Participants received losartan for 30–90 days, while all other ocular medications remained the same. A clinical improvement was seen in 4 of the 6 eyes; UDVA improved from 0.65 to 0.43 logMAR. Three eyes achieved a gain of 0.20 or greater logMAR, which was clinically significant. OCT revealed a reduction in fibrosis in some cases. The authors wrote that a positive clinical effect could reach statistical significance with a larger sample size. Further randomized controlled studies could also establish dosing and long-term safety. Editors' note: The most-viewed papers from JCRS and JCRO were taken from those published from January through October 2026. This OCT image from "Artificial corneal implant in iridocorneal endothelial syndrome with secondary glaucoma: case report" shows KeraKlear implanted and open angles at postop month 1. Reprinted with permission from: Yip KLH, et al. Artificial corneal implant in iridocorneal endothelial syndrome with secondary glaucoma: case report. JCRO: JCRS Online Case Reports. 2026;14(1). https://doi.org/10.1097/j.jcro. 0000000000000228

• Cover